In a landmark moment for India's space ambitions, Indian astronaut Shubhanshu Shukla has blasted off to the International Space Station (ISS) as part of the Axiom-4 mission , marking the country's return to human spaceflight after a 41-year hiatus . This historic launch from NASA’s Kennedy Space Center in Florida has not only reignited national pride but also officially kickstarted India’s human spaceflight programme . The mission, operated by Axiom Space , includes a four-member international crew that will spend 14 days in orbit , conducting scientific research, outreach programs, and various commercial activities. This momentous occasion places India among a select group of nations capable of sending humans into space and reflects the growing prowess of the Indian space sector . A New Chapter: Shubhanshu Shukla and India’s Astronautical Comeback The last Indian to go to space was Rakesh Sharma in 1984, aboard the Soviet spacecraft Soyuz T-11. Now, in 2025, Shubhanshu...
IIT Guwahati’s Hydrogel Innovation for Breast Cancer Therapy

Content
Researchers from IIT Guwahati have developed a protein-based injectable hydrogel for targeted breast cancer treatment.
Key features:
Peptide-Based: Made from ultra-short, protein-derived peptides.
Biocompatibility: Safe for use in the body and biodegradable.
Stability: Remains insoluble and stable at injection sites in body fluids.
Tissue-Mimicking: Its 3D polymer structure mimics living tissues, enhancing biomedical suitability.
Water Retention: Absorbs and retains fluids, crucial for drug delivery applications.
This innovative hydrogel offers significant potential for localized breast cancer therapies, promising better precision and fewer side effects.